Siste fortfatter Kreftregisteret

Sist oppdatert:

Publisert 2020

Backmann HALarsen MDanielsen ASHofvind S (2020)
Time of day and mammographic reader performance in a population-based breast cancer screening programme
J Med Screen0969141320953206
DOI 10.1177/0969141320953206PubMed 32862773

Berge LAMAndreassen BKStenehjem JSHeir TFuru KJuzeniene ARoscher ILarsen IKGreen ACVeierød MBRobsahm TE (2020)
Use of Antidepressants and Risk of Cutaneous Melanoma: A Prospective Registry-Based Case-Control Study
Clin Epidemiol12193-202
DOI 10.2147/CLEP.S241249PubMed 32110111

Berge LAMAndreassen BKStenehjem JSHeir TKarlstad ØJuzeniene AGhiasvand RLarsen IKGreen ACVeierød MBRobsahm TE (2020)
Use of Immunomodulating Drugs and Risk of Cutaneous Melanoma: A Nationwide Nested Case-Control Study
Clin Epidemiol121389-1401
DOI 10.2147/CLEP.S269446PubMed 33376408

Blindheim AFosså SBabigumira RMyklebust TÅHaug EArum CJAndreassen BK (2020)
T1 bladder cancer in Norway: treatment and survival
Scand J Urol54 (5)370-375
DOI 10.1080/21681805.2020.1803401PubMed 32783590

Brancher SStøer NCWeiderpass EDamhuis RAMJohannesen TBBotteri EStrand TE (2020)
Metformin use and lung cancer survival: a population-based study in Norway
Br J Cancer
DOI 10.1038/s41416-020-01186-9PubMed 33262518

Burton JUmu SULangseth HGrotmol TGrimsrud TKHaugen TBRounge TB (2020)
Serum RNA Profiling in the 10-Years Period Prior to Diagnosis of Testicular Germ Cell Tumor
Front Oncol10574977
DOI 10.3389/fonc.2020.574977PubMed 33251139

Daltveit DSKlungsøyr KEngeland AEkbom AGissler MGlimelius IGrotmol TMadanat-Harjuoja LOrding AGSæther SMMSørensen HTTroisi RBjørge T (2020)
Cancer risk in individuals with major birth defects: large Nordic population based case-control study among children, adolescents, and adults
DOI 10.1136/bmj.m4060PubMed 33268348

Dianatinasab MRezaian MHaghighatNezad EBagheri-Hosseinabadi ZAmanat SRezaeian SMasoudi AGhiasvand R (2020)
Dietary Patterns and Risk of Invasive Ductal and Lobular Breast Carcinomas: A Systematic Review and Meta-analysis
Clin Breast Cancer20 (4)e516-e528
DOI 10.1016/j.clbc.2020.03.007PubMed 32362500

Enerly EBerger SKjær SKSundström KCampbell STryggvadóttir LMunk CHortlund MThomas Group. Electronic address: thomas_group@merck.comJoshi ASaah AJNygård M (2020)
Use of real-world data for HPV vaccine trial follow-up in the Nordic region
Contemp Clin Trials92105996
DOI 10.1016/j.cct.2020.105996PubMed 32247041

Fosså SDAas KMüller CJerm MBTandstad TLilleby WKvåle RGulbrandsen JHaug EMyklebust TA (2020)
Definitive radiotherapy for prostate cancer in Norway 2006-2015: Temporal trends, performance and survival
Radiother Oncol15533-41 (in press)
DOI 10.1016/j.radonc.2020.10.022PubMed 33096165

Frisch DBecker DWojewodzic MW (2020)
Dissecting the Transcriptomic Basis of Phenotypic Evolution in an Aquatic Keystone Grazer
Mol Biol Evol37 (2)475-487
DOI 10.1093/molbev/msz234PubMed 31722403

Graue RLönnberg SSkare GBSaether SMMBjørge T (2020)
Atypical glandular lesions of the cervix and risk of cervical cancer
Acta Obstet Gynecol Scand99 (5)582-590
DOI 10.1111/aogs.13790PubMed 31853943

Hashim DEngesæter BBaadstrand Skare GCastle PEBjørge TTropé ANygård M (2020)
Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening
Br J Cancer122 (11)1715-1723
DOI 10.1038/s41416-020-0790-1PubMed 32242098

Hektoen HHRobsahm TEAndreassen BKStenehjem JSAxcrona KMondul AGislefoss RE (2020)
Lifestyle associated factors and risk of urinary bladder cancer: A prospective cohort study from Norway
Cancer Med9 (12)4420-4432
DOI 10.1002/cam4.3060PubMed 32319230

Hjerkind KVLarsen IKAaserud SMøller BUrsin G (2020)
Cancer incidence in non-immigrants and immigrants in Norway
Acta Oncol59 (11)1275-1283
DOI 10.1080/0284186X.2020.1817549PubMed 32930622

Hofvind S (2020)
Screening with 3D mammography – more accurate, but more costly
Tidsskr Nor Laegeforen140 (5)
DOI 10.4045/tidsskr.20.0046PubMed 32238960

Hofvind SMangerud GUrsin G (2020)
Misleading and tendentious comments about information in the Norwegian Breast Cancer Screening Programme
Tidsskr Nor Laegeforen140 (6)
DOI 10.4045/tidsskr.20.0246PubMed 32321230

Hofvind SSebuødegård S (2020)
S. Hofvind and colleagues respond
Tidsskr Nor Laegeforen140 (8)
DOI 10.4045/tidsskr.20.0379PubMed 32463197

Hofvind SSebuødegård SBotteri E (2020)
Response to Zahl
J Natl Cancer Inst112 (11)1175
DOI 10.1093/jnci/djaa130PubMed 32986835

Hovda TTsuruda KHoff SRSahlberg KKHofvind S (2020)
Radiological review of prior screening mammograms of screen-detected breast cancer
Eur Radiol
DOI 10.1007/s00330-020-07130-yPubMed 33001307

Jakobsen JBabigumira RDanielsen MGrimsrud TKOlsen RRosting CVeierød MBKjærheim K (2020)
Work Conditions and Practices in Norwegian Fire Departments From 1950 Until Today: A Survey on Factors Potentially Influencing Carcinogen Exposure
Saf Health Work11 (4)509-516
DOI 10.1016/ 33329918

Johansson ALVStensheim H (2020)
Epidemiology of Pregnancy-Associated Breast Cancer
Adv Exp Med Biol125275-79
DOI 10.1007/978-3-030-41596-9_9PubMed 32816264

Kitahara CMSlettebø Daltveit DEkbom AEngeland AGissler MGlimelius IGrotmol TTrolle Lagerros YMadanat-Harjuoja LMännistö TToft Sørensen HTroisi RBjørge T (2020)
Maternal health, in-utero, and perinatal exposures and risk of thyroid cancer in offspring: a Nordic population-based nested case-control study
Lancet Diabetes Endocrinol (in press)
DOI 10.1016/S2213-8587(20)30399-5PubMed 33347809

Knudsen MDBotteri EHolme ØHjartåker ASong MThiis-Evensen ENorvard ERSchult ALRandel KRHoff GBerstad P (2020)
Association between lifestyle and site-specific advanced colorectal lesions in screening with faecal immunochemical test and sigmoidoscopy
Dig Liver Dis (in press)
DOI 10.1016/j.dld.2020.11.021PubMed 33309513

Knudsen MDHoff GTidemann-Andersen IBodin GEØvervold SBerstad P (2020)
Public Awareness and Perceptions of Colorectal Cancer Prevention: a Cross-Sectional Survey
J Cancer Educ
DOI 10.1007/s13187-020-01721-5PubMed 32112366

Lambert PCAndersson TMRutherford MJMyklebust TÅMøller B (2020)
Reference-adjusted and standardized all-cause and crude probabilities as an alternative to net survival in population-based cancer studies
Int J Epidemiol49 (5)1614-1623
DOI 10.1093/ije/dyaa112PubMed 32829393

Larsen IKMyklebust TÅBabigumira RVinberg EMøller BUrsin G (2020)
Education, income and risk of cancer: results from a Norwegian registry-based study
Acta Oncol59 (11)1300-1307
DOI 10.1080/0284186X.2020.1817548PubMed 32924698

Larsen MLilleborge MVigeland EHofvind S (2020)
Self-reported symptoms among participants in a population-based screening program
DOI 10.1016/j.breast.2020.08.015PubMed 32927237

Larsen MMoshina NSagstad SHofvind S (2020)
Factors associated with attendance and attendance patterns in a population-based mammographic screening program
J. Med. Screen.0969141320932945

Lilleborge MFalk RSHofvind S (2020)
Number of prior negative screening outcomes does not influence future risk of breast cancer
Eur J Epidemiol35 (6)549-556
DOI 10.1007/s10654-020-00645-0PubMed 32430839

Lund E (2020)
La tallene få tale
Tidsskr Nor Laegeforen140 (12)
DOI 10.4045/tidsskr.20.0490PubMed 32900169

Martinecz AWojewodzic MW (2020)
Could bacteriophages be the answer to the COVID-19 crisis?
Expert Rev Anti Infect Ther
DOI 10.1080/14787210.2021.1836960PubMed 33047989

Moshina NAase HSDanielsen ASHaldorsen ISLee CIZackrisson SHofvind S (2020)
Comparing Screening Outcomes for Digital Breast Tomosynthesis and Digital Mammography by Automated Breast Density in a Randomized Controlled Trial: Results from the To-Be Trial
Radiology297 (3)522-531
DOI 10.1148/radiol.2020201150PubMed 32930649

Myklebust TÅAndersson TBardot AVernon SGavin AFitzpatrick DJerm MBRutherford MParkin DMSasieni PArnold MSoerjomataram IBray FLambert PCMøller B (2020)
Can different definitions of date of cancer incidence explain observed international variation in cancer survival? An ICBP SURVMARK-2 study
Cancer Epidemiol67101759
DOI 10.1016/j.canep.2020.101759PubMed 32544801

Nilbert MThomsen LAWinther Jensen JMøller HBorre MWidenlou Nordmark ALambe MBrändström HKørner HMøller BUrsin G (2020)
The power of empirical data; lessons from the clinical registry initiatives in Scandinavian cancer care
Acta Oncol59 (11)1343-1356
DOI 10.1080/0284186X.2020.1820573PubMed 32981417

Nilssen YBrustugun OTEriksen MTHaug ESNaume BMøller B (2020)
Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016
BMC Cancer20 (1)488
DOI 10.1186/s12885-020-06979-yPubMed 32473650

Orumaa MKjaer SKDehlendorff CMunk COlsen AOHansen BTCampbell SNygård M (2020)
The impact of HPV multi-cohort vaccination: Real-world evidence of faster control of HPV-related morbidity
Vaccine38 (6)1345-1351
DOI 10.1016/j.vaccine.2019.12.016PubMed 31917039

Pedersen IBBretthauer MKalager MLøberg MHoff GMatapour SHugin SFrigstad SOSeip BKleist BALøvdal LBotteri EHolme Ø (2020)
Incomplete endoscopic resection of colorectal polyps: a prospective quality assurance study
DOI 10.1055/a-1243-0379PubMed 32961579

Raju SCViljakainen HFigueiredo RAONeuvonen PJEriksson JGWeiderpass ERounge TB (2020)
Antimicrobial drug use in the first decade of life influences saliva microbiota diversity and composition
Microbiome8 (1)121
DOI 10.1186/s40168-020-00893-yPubMed 32825849

Randel KRSchult ALBotteri EHoff GBretthauer MUrsin GNatvig EBerstad PJørgensen ASandvei PKOlsen MEFrigstad SODarre-Næss ONorvard ERBolstad NKørner HWibe AWensaas KAde Lange THolme O (2020)
Colorectal cancer screening with repeated fecal immunochemical test versus sigmoidoscopy: baseline results from a randomized trial
Gastroenterology (in press)
DOI 10.1053/j.gastro.2020.11.037PubMed 33227280

Rehm JShield KDWeiderpass E (2020)
Alcohol consumption. A leading risk factor for cancer
Chem Biol Interact331109280
DOI 10.1016/j.cbi.2020.109280PubMed 33010221

Reigstad MMStoreng RFuru KBakken IJEngeland ALarsen IK (2020)
Validation of Assisted Reproductive Technology in the Medical Birth Registry of Norway Versus the Norwegian Prescription Database
Epidemiology31 (5)681-686
DOI 10.1097/EDE.0000000000001228PubMed 32639249

Schwartz GGTretli SKlug MGRobsahm TE (2020)
Women who develop ovarian cancer show an increase in serum calcium and a decrease in serum albumin. A longitudinal study in the Janus Serum Bank Cohort
Gynecol Oncol159 (1)264-269
DOI 10.1016/j.ygyno.2020.07.006PubMed 32723677

Sebuødegård SBotteri EHofvind S (2020)
Breast Cancer Mortality After Implementation of Organized Population-Based Breast Cancer Screening in Norway
J Natl Cancer Inst112 (8)839-846
DOI 10.1093/jnci/djz220PubMed 31848605

Skjerven HKDanielsen ASSchlichting ESahlberg KKHofvind S (2020)
Surgical treatment of breast cancer in Norway 2003-18
Tidsskr. Nor. Laegeforen.140 (15)1544-1550

Skjerven HKDanielsen ASSchlichting ESahlberg KKHofvind S (2020)
Surgical treatment of breast cancer in Norway 2003-2018
Tidsskr Nor Laegeforen140 (15)
DOI 10.4045/tidsskr.20.0090PubMed 33118768

Sondén ECBSebuødegård SKorvald CLømo JSchlichting EBrandal SHBHofvind S (2020)
Cosmetic breast implants and breast cancer
Tidsskr Nor Laegeforen140 (3)
DOI 10.4045/tidsskr.19.0266PubMed 32105043

Soper BCNygård MAbdulla GMeng RNygård JF (2020)
A hidden Markov model for population-level cervical cancer screening data
Stat Med39 (25)3569-3590
DOI 10.1002/sim.8681PubMed 32854166

Stenehjem JSBabigumira RHosgood HDVeierød MBSamuelsen SOBråtveit MKirkeleit JRothman NLan QSilverman DTFriesen MCRobsahm TEKjærheim KAndreassen BKShala NKLiu FCStrand LÅGrimsrud TK (2020)
Cohort Profile: The Norwegian Offshore Petroleum Workers (NOPW) Cohort
Int J Epidemiol (in press)
DOI 10.1093/ije/dyaa107PubMed 32879941

Stenehjem JSStøer NCGhiasvand RGrimsrud TKBabigumira RRees JRNilsen LTJohnsen BThorsby PMVeierød MBRobsahm TE (2020)
Prediagnostic serum 25-hydroxyvitamin D and melanoma risk
Sci Rep10 (1)20129
DOI 10.1038/s41598-020-77155-2PubMed 33208828

Støer NCBotteri EThoresen GHKarlstad ØWeiderpass EFriis SPottegård AAndreassen BK (2020)
Drug Use and Cancer Risk: A Drug-Wide Association Study (DWAS) in Norway
Cancer Epidemiol Biomarkers Prev (in press)
DOI 10.1158/1055-9965.EPI-20-1028PubMed 33144282

Şuteu OBlaga MLNygård MLeinonen MKNicula FPăiş RCoza DCadariu PAMelnic AAndreassen THashim DWeiderpass E (2020)
Prevalence of positive screening test results and agreement between cytology and human papillomavirus testing in primary cervical cancer screening in North-Western Romania
Eur J Cancer Prev29 (2)141-148
DOI 10.1097/CEJ.0000000000000522PubMed 31033568

Thøgersen HMøller BÅsli LMBhargava SKvåle RFjellbirkeland LRobsahm TEAaserud SBabigumira RLarsen IK (2020)
Waiting times and treatment following cancer diagnosis: comparison between immigrants and the Norwegian host population
Acta Oncol59 (4)376-383
DOI 10.1080/0284186X.2019.1711167PubMed 31920119

Trewin CBHjerkind KVJohansson ALVStrand BHKiserud CEUrsin G (2020)
Socioeconomic inequalities in stage-specific breast cancer incidence: a nationwide registry study of 1.1 million young women in Norway, 2000-2015
Acta Oncol59 (11)1284-1290
DOI 10.1080/0284186X.2020.1753888PubMed 32319848

Trewin CBJohansson ALVHjerkind KVStrand BHKiserud CEUrsin G (2020)
Stage-specific survival has improved for young breast cancer patients since 2000: but not equally
Breast Cancer Res Treat182 (2)477-489
DOI 10.1007/s10549-020-05698-zPubMed 32495000

Tsuruda KMHovda TBhargava SVeierød MBHofvind S (2020)
Survival among women diagnosed with screen-detected or interval breast cancer classified as true, minimal signs, or missed through an informed radiological review
Eur Radiol
DOI 10.1007/s00330-020-07340-4PubMed 33180162

Umu SULangseth HKeller AMeese EHelland ÅLyle RRounge TB (2020)
A 10-year prediagnostic follow-up study shows that serum RNA signals are highly dynamic in lung carcinogenesis
Mol Oncol14 (2)235-247
DOI 10.1002/1878-0261.12620PubMed 31851411

Ursin GGrimsrud TKGulbrandsen JJakobsen EJohannesen TBLarønningen SRobsahm TESeglem AHMøller BLarsen IK (2020)
Kreft i Norge
Tidsskr Nor Laegeforen140 (17)
DOI 10.4045/tidsskr.20.0853PubMed 33231394

Viljakainen JRaju SCViljakainen HFigueiredo RAORoos EWeiderpass ERounge TB (2020)
Meal Regularity Plays a Role in Shaping the Saliva Microbiota
Front Microbiol11757
DOI 10.3389/fmicb.2020.00757PubMed 32390990